Clinical Trial: A Trial of SHR-A2102 With Adebrelimab in Locally Advanced or Metastatic Urothelial Carcinoma

U.S., Feb. 7 -- ClinicalTrials.gov registry received information related to the study (NCT07393542) titled 'A Trial of SHR-A2102 With Adebrelimab in Locally Advanced or Metastatic Urothelial Carcinoma' on Jan. 30.

Brief Summary: The study is being conducted to evaluate the efficacy of SHR-A2102 with adebrelimab versus gemcitabine in combination with cisplatin/carboplatin in previously untreated locally advanced or metastatic urothelial carcinoma.

Study Start Date: Feb., 2026

Study Type: INTERVENTIONAL

Condition: Locally Advanced or Metastatic Urothelial Carcinoma

Intervention: DRUG: SHR-A2102 and Adebrelimab

SHR-A2102 and Adebrelimab injection

DRUG: Gemcitabine and cisplatin / carboplatin

Gemcitabine injection and cisplatin inject...